Dr Amanda Mather

Senior Lecturer
Medicine, Northern Clinical School

Telephone +61 2 9926 6543
Fax +61 2 9436 3719

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Panchapakesan, U., Pegg, K., Gross, S., Gangadharan Komala, M., Mudaliar, H., Forbes, J., Pollock, C., Mather, A. (2013). Effects of SGLT2 inhibition in human kidney proximal tubular cells - renoprotection in diabetic nephropathy? PLoS One, 8(2), 1-8. [More Information]
  • Panchapakesan, U., Mather, A., Pollock, C. (2013). Role of glp-1 and dpp-4 in diabetic nephropathy and cardiovascular disease. Clinical Science, 124(1), 17-26. [More Information]
  • Gangadharan Komala, M., Panchapakesan, U., Pollock, C., Mather, A. (2013). Sodium glucose cotransporter 2 and the diabetic kidney. Current Opinion In Nephrology And Hypertension, 22(1), 113-119. [More Information]
  • Mather, A., Pollock, C. (2011). Glucose handling by the kidney. Kidney International, 79(Suppl 120), S1-S6. [More Information]
  • Mather, A., Pollock, C. (2010). Renal glucose transporters: novel targets for hyperglycemia management. Nature Reviews Nephrology, 6(5), 307-11. [More Information]
  • Mather, A., Chen, X., McGinn, C., Field, M., Sumual, S., Mangiafico, S., Zhang, Y., Kelly, D., Pollock, C. (2009). High glucose induced endothelial cell growth inhibition is associated with an increase in TGF-{beta}(1) secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway. The International Journal of Biochemistry and Cell Biology, 41(3), 561-569. [More Information]
  • Pollock, C., Mather, A. (2006). A current understanding of the pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzymeA reductase inhibitors on vascular disease. Current Topics in Pharmacology, 10(2), 89-97.

2013

  • Panchapakesan, U., Pegg, K., Gross, S., Gangadharan Komala, M., Mudaliar, H., Forbes, J., Pollock, C., Mather, A. (2013). Effects of SGLT2 inhibition in human kidney proximal tubular cells - renoprotection in diabetic nephropathy? PLoS One, 8(2), 1-8. [More Information]
  • Panchapakesan, U., Mather, A., Pollock, C. (2013). Role of glp-1 and dpp-4 in diabetic nephropathy and cardiovascular disease. Clinical Science, 124(1), 17-26. [More Information]
  • Gangadharan Komala, M., Panchapakesan, U., Pollock, C., Mather, A. (2013). Sodium glucose cotransporter 2 and the diabetic kidney. Current Opinion In Nephrology And Hypertension, 22(1), 113-119. [More Information]

2011

  • Mather, A., Pollock, C. (2011). Glucose handling by the kidney. Kidney International, 79(Suppl 120), S1-S6. [More Information]

2010

  • Mather, A., Pollock, C. (2010). Renal glucose transporters: novel targets for hyperglycemia management. Nature Reviews Nephrology, 6(5), 307-11. [More Information]

2009

  • Mather, A., Chen, X., McGinn, C., Field, M., Sumual, S., Mangiafico, S., Zhang, Y., Kelly, D., Pollock, C. (2009). High glucose induced endothelial cell growth inhibition is associated with an increase in TGF-{beta}(1) secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway. The International Journal of Biochemistry and Cell Biology, 41(3), 561-569. [More Information]

2006

  • Pollock, C., Mather, A. (2006). A current understanding of the pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzymeA reductase inhibitors on vascular disease. Current Topics in Pharmacology, 10(2), 89-97.

To update your profile click here. For support on your academic profile contact .